Press Releases

Gallego, Kelly Urge Arizona House Republicans to Return to D.C. and Work Together to Prevent Health Care Cost Spikes and End Government Shutdown

“There is no time to waste. We invite you to come back to Washington and work with us to keep Arizonans from facing higher health care costs and get the government back open.” WASHINGTON — Today, Arizona Senators Ruben Gallego and Mark Kelly sent a reply to Arizona’s Republican House delegation urging them to return to Washington and work together to prevent steep health care premium spikes for Arizonans and reopen the federal government. In their letter, Gallego and Kelly warn that if Congress fails to act, the expiration of Affordable Care Act enhanced premium tax credits will cause premiums to skyrocket for more than 300,000 Arizonans who rely on

Read More »

ICYMI: Gallego Visits Globe-Miami After Devastating Flooding

ARIZONA – Yesterday, Senator Ruben Gallego (D-AZ) visited the towns of Globe and Miami to survey the damage of historic flooding that killed three people in Arizona last week. While there, he heard directly from impacted residents and small business owners, and thanked first responders and volunteers supporting the ongoing recovery efforts. See coverage below:   Arizona’s Family (Phoenix, AZ): Gallego: “We can’t have something like this happen again. We now know what the problem is. We – when I say we, the federal government, local government, state government, and to some degree local businesses – need to come together and come up with an actual, real infrastructure plan.”

Read More »

Gallego Presses Pfizer on Secret Trump Drug Pricing Deal

WASHINGTON – Today, Senator Ruben Gallego (D-AZ) called on Pfizer to provide answers about its newly announced agreement with the Trump administration to implement “Most Favored Nation” (MFN) pricing in Medicaid and launch a new drug purchasing platform, TrumpRx.gov. READ MORE: Gallego demands transparency in Trump’s deal with Pfizer (The Hill) “To date, few details about this deal have been made public. While the White House touted the agreement as a win for patients, neither the Administration nor Pfizer has disclosed which drugs are covered, what prices have been agreed to, or how patients will benefit,” Gallego wrote in a letter to Pfizer CEO Dr. Albert Bourla. “The lack of transparency surrounding this

Read More »